Our Mission
The ACC Nevada Chapter is dedicated to advancing the field of cardiovascular care through innovation, advocacy, and professional development, ensuring that Nevada’s clinicians are equipped to meet the evolving health challenges of our state.
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- 20-Year Outcomes For PVI in Patients With Drug-Refractory Paroxysmal AFibTwenty years after pulmonary vein isolation (PVI) during catheter ablation, stable sinus rhythm was maintained in a quarter of patients with symptomatic drug-refractory paroxysmal atrial fibrillation (PAF), including those taking antiarrhythmic drugs and those who had multiple ablation procedures, according to findings from a study published Feb. 17 in JACC: Clinical Electrophysiology.
- Medtronic Clinician Update on New Evolut Valve Data Reinforces Need For Patient DialogueMedtronic has issued a letter and developed web resources providing an update on long-term reintervention rates associated with its Evolut R and Evolut PRO transcatheter heart valves, drawing on complete six-year and partial seven-year follow-up data from the Evolut Low-Risk Trial published on Feb. 16 in JACC.
- AI-Enabled Clinician: Access to and Implementation of AI-Quantified Plaque Analysis TechnologyIn this episode, ACC Chief Innovation Officer Dr. Ami Bhatt is joined by Dr. Geoffrey Rose to explore the impact of artificial intelligence (AI)-enabled plaque analysis and its integration into clinical workflows.
- ACC Efforts Help Propel Legislation to Stabilize Medicare Physician PaymentsEstablishing sustainable Medicare payment practices has long been a top priority for ACC Advocacy, and key bills introduced in Congress offer a promising pathway toward real, lasting reform.
- ESC 0/1-Hour Algorithm vs. High-STEACS 0/2-Hour or 0/3-Hour Pathway For NSTEMI DiagnosisBoth the European Society of Cardiology 0/1-hour algorithm (ESC 0/1h-algorithm) and the high-sensitivity troponin in the evaluation of patients with acute coronary syndrome 0/2-hour or 0/3-hour pathway (High-STEACS 0/2h-0/3h-pathway) demonstrated "comparable and excellent performance" in diagnosing patients presenting with acute chest discomfort, according to a prospective, multicenter study published in JACC.
Become an ACC Member Today!
Already a Member?
Access your profile | Renew your membership | Personalize your ACC.org







Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: